The incidence of hepatitis C (HCV) infection and associated risk factors were prospectively assessed in a cohort of 6,734 Egyptians from 2 rural villages who were negative for antibodies to HCV (anti-HCV). Initial and follow-up sera were tested for anti-HCV by enzyme immunoassay (EIA), and possible
Maternal-infant transmission of hepatitis B in Egypt
β Scribed by Kenneth C. Hyams; Nadia Mohamed Osman; Eman Mohamed Khaled; Afaf Abd El-Wahab Koraa; Imam Zagloul Imam; Nemat M. El-Ghorab; Michael A. Dunn; James N. Woody
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 439 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
In order to determine whether maternal-infant (vertical) transmission of hepatitis B is a common route of infection leading to chronic antigenemia in Egypt, 901 asymptomatic women in labor were evaluated. Forty-three women (4.8 percent) were positive for HBsAg, but only one woman was positive for HBeAg. From one year of observation of children born to 13 of the HBsAg-positive mothers, vertical transmission of hepatitis B was estimated to have occurred in approximately 1.7% of births, with chronic antigenemia resulting from 0.6% of births. It was also possible to observe 29 children born to women negative for HBsAg. Horizontal transmission of hepatitis B occurred in 17.2 percent of these children during the first year of life. Maternal-infant transmission of hepatitis B at birth does not appear to be the predominant mechanism of hepatitis B transmission or a cammon cause of chronic antigenemia in Egypt. The first year after birth appears to be a more important period of hepatitis B transmission.
Therefore, vaccination of all children at birth with hepatitis B vaccine could be an effective vaccine strategy despite a low incidence of vertical hepatitis B transmission.
π SIMILAR VOLUMES
## Abstract Over 90% of infants infected with hepatitis B virus (HBV) caused by motherβtoβinfant transmission will evolve to carrier status, and this cannot be prevented until widespread administration of the HB vaccine and hepatitis B immune globulin (HBIG) is implemented. This prospective study o
The significance of IgM and IgG class antibodies to hepatitis B virus (HBV) core component (anti-HBc) was investigated in a study of maternal-fetal HBV transmission. An IgM anti-HBc response was lacking in the majority (49/53) of HBV-infected infants. This antibody thus cannot be used as an indicato
Objective: To measure the risk of perinatal transmission of HBV in chronic carriers who undergo amniocentesis. Methods: This was a prospective, longitudinal study from 1990 to 1995 of women who were HBV carriers and underwent amniocentesis. The infants of these women were followed from birth to one